| ¿µ¹® | basement membrane | ÇÑ±Û | ¹Ù´Ú¸·, ±âÀú¸· |
|---|---|---|---|
| ¼³¸í | »óÇǼ¼Æ÷, ±ÙÀ°¼¼Æ÷, ½Å°æÁ¶Á÷°ú ±×°ÍµéÀÇ ¹Ù±ùÂÊ °áÇÕÁ¶Á÷ÀÇ °æ°è¿¡ ÀÖ´Â Á¡¾×´Ù´çÁú°ú ´Ü¹éÁú·Î ±¸¼ºµÈ ¾ãÀº ¸·. ±âÃʸ· ¶Ç´Â °æ°è¸·À̶ó°íµµ ÇÑ´Ù. µÎ²²´Â 50~80nmÀÌ´Ù. ±âÀú¸·Àº 20~30nm °£°ÝÀ¸·Î ´Ã¾î¼± Á·¼¼Æ÷·Î µÈ »óÇǼ¼Æ÷ÀÇ 3ÃþÀ¸·Î µÇ¾î ÀÖ°í, ºÐÀÚ·® 40,000~60,000ÀÇ ¹°ÁúÀ» Åõ°úÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. ¶ÇÇÑ Ç¥ÇÇ¿Í ÁøÇÇÀÇ °æ°è·Î ¿µ¾çÀ» °ø±ÞÇÏ´Â ±âÁö ¿ªÇÒÀ» ÇÑ´Ù. ÁÖ·Î ¼¶À¯¸¦ Æ÷ÇÔÇÏ¿© ´Ù´ç·ù·Î µÇ¾î Àִµ¥, ÇöÀúÇÏ°Ô ¹ß´ÞµÇ¾î ÀÖ´Â ºÎºÐ°ú ±×·¸Áö ¾ÊÀº ºÎºÐÀÌ ÀÖ´Ù. ºñÁ¡¸·¿¡¼´Â Á¡¸·»óÇÇÀÇ ¹Ø¿¡ ¹ß´ÞÇÑ ±âÀú¸·ÀÌ ÀÖ´Ù. ÀÌ ¸· À§¿¡ û°¢¼ö¿ë¼¼Æ÷ÀÎ Åм¼Æ÷¸¦ °®´Â ÄÚ¸£Æ¼±â°üÀÌ Á¸ÀçÇÑ´Ù. ±âÀú¸·Àº ÀüÁ¦°¡ À½Àü±â ¼ºÁúÀ» °¡Áö°í ÀÖ¾î ¾çÀü±â¸¦ °¡Áø ¹°ÁúÀÌ Åõ°úÇϱ⠽±´Ù. ±âÀú¸·ÀÌ ÆØÈÇϰųª ¹Ðµµ°¡ ³·¾ÆÁö¸é ´Ü¹éÁúÀÌ Åë°úÇÏ¿© ´Ü¹é´¢¸¦ ÀÏÀ¸Å°°í, ±âÀú¸·¿¡ ±Õ¿-ÆÄ±« µîÀÌ ÀϾ¸é ÀûÇ÷±¸ µîÀÇ Ç÷¾× °íÇü¼ººÐÀÌ Åõ°úÇÏ¿© Ç÷´¢°¡ µÈ´Ù. |
||
| ¿µ¹® | carcinoembryonic antigen | ÇÑ±Û | ¾Ï¹è¾ÆÇ׿ø |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ žÆÀÇ ÀåÁ¶Á÷¿¡¼ Á¤»óÀûÀ¸·Î Á¸ÀçÇÏ´Â ¹°Áú·Î žƱâ ÀÌÈÄ¿¡´Â Á¸ÀçÇÏÁö ¾Ê´Â ¹°ÁúÀÌ´Ù. ±×·¯³ª À§, °£, ÇãÆÄ µîÀÇ ¾ÏÀÌ ÀÖ´Â °æ¿ì¿¡ ¼ºÀο¡¼µµ Á¸ÀçÇÑ´Ù. À̸¦ ÀÌ¿ëÇØ¼ ¾ÏÀÇ Ä¡·áÈ¿°ú ÆÇÁ¤À̳ª Àç¹ß¿©ºÎÀÇ Á¶»ç¿¡ ÀÌ¿ëÇÑ´Ù. |
||
| ¿µ¹® | antigen | ÇÑ±Û | Ç׿ø |
|---|---|---|---|
| ¼³¸í | ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ¾î¶°ÇÑ ¹°Áú. ¿©±â¿¡¼ ¸»Çϴ ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ̶õ ºñƯÀÌÀûÀÎ ¸é¿ª¹ÝÀÀ°ú´Â ¹Ý´ëµÇ´Â Àǹ̷Π±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â Ç×ü³ª ±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â ¼¼Æ÷¸¦ ¸¸µå´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | hyaline membrane disease | ÇÑ±Û | À¯¸®Áú¸·º´ |
|---|---|---|---|
| ¼³¸í | ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½ÃŰ´Â ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀÎ º´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êÈź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. ȯ¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú ÷´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈÄ´Â Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־ ġ·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù. |
||
| PBM | peak bone mass; peripheral basement membrane; peripheral blood mononuclear [cell]; placental basemen... |
|---|---|
| TBM | total body mass; tracheobronchiomegaly; trophoblastic basement membrane; tuberculous meningitis; tub... |
| BM | Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra... |
| MSA | major serologic antigen; male-specific antigen; mannitol salt agar; Medical Services Administration;... |
| HLA | histocompatibility leukocyte antigen; histocompatibility locus antigen; homologous leukocyte antibod... |
| GBM | Anti-glomerular basement membrane |
|---|---|
| anti-GBM | Anti-glomerular basement membrane |
| TBM | Anti-tubular basement membrane |
| BM | Basement Membrane |
| BMZ | Basement membrane zone |
| anti-basement membrane antibody | Autoantibodies to renal glomerular basement membrane antigens. (05 Mar 2000) |
|---|---|
| anti-basement membrane glomerulonephritis | Glomerulonephritis resulting from anti-basement membrane antibodies, characterised by smooth linear deposits of IgG and C3 along glomerular capillary walls; includes rapidly progressive glomerulonephritis and glomerulonephritis in Goodpasture's syndrome. (05 Mar 2000) |
| anti-basement membrane nephritis | Glomerulonephritis produced by autologous or heterologous antibodies to the glomerular capillary basement membranes, the latter known as anti-kidney serum nephritis. (05 Mar 2000) |
| anti-glomerular basement membrane disease | Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome. (12 Dec 1998) |
| basement membrane | <cell biology> Extracellular matrix characteristically found under epithelial cells. There are two distinct layers: the basal lamina, immediately adjacent to the cells, is a product of the epithelial cells themselves and contains collagen type IV and the reticular lamina is produced by fibroblasts of the underlying connective tissue and contains fibrillar collagen. (15 Nov 1997) |
| basement | The outer wall of the ground story of a building, or of a part of that story, when treated as a distinct substructure. (See Base, 3) Hence: The rooms of a ground floor, collectively. <anatomy> Basement membrane, a delicate membrane composed of a single layer of flat cells, forming the substratum upon which, in many organs, the epithelioid cells are disposed. Origin: F. Soubassement. Of uncertain origin. Cf. Base, Bastion. Source: Websters Dictionary (01 Mar 1998) |
| basement lamina | <cell biology> Extracellular matrix characteristically found under epithelial cells. There are two distinct layers: the basal lamina, immediately adjacent to the cells, is a product of the epithelial cells themselves and contains collagen type IV and the reticular lamina is produced by fibroblasts of the underlying connective tissue and contains fibrillar collagen. (15 Nov 1997) |
| Epithelial membrane antigen | <cell biology> Heavily glycosylated membrane glycoprotein. Encoded by the MUC 1 gene, has a molecular weight of around 300 kD, more than half of which is O linked glycan. There is a 69 residue cytoplasmic domain and the extracellular domain may extend hundreds of nanometres beyond the plasma membrane, the increased expression in carcinoma cells may reduce the adhesion and mask antigenic properties of the cells. Similar functions are ascribed to ASGP, epiglycanin and leucosialin. (18 Nov 1997) |
| acetone-insoluble antigen | A diphosphatidyl glycerol that is found in the membrane of Treponema pallidum and is the antigen detected by the Wasserman test for syphilis. (18 Nov 1997) |
| allogeneic antigen | Genetic variations of the same antigens within a given species. (05 Mar 2000) |
| antigen | Virus coded cell surface antigens that appear soon after the infection of a cell by virus, but before virus replication has begun. See: early gene. (18 Nov 1997) |
| antigen-antibody complex | The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes immune complex diseases. If the antigen is polyvalent the complex may be insoluble. Immune complexes activate complement through the classical pathway. See: glomerulonephritis, Arthus reaction, type III hypersensitivity. (12 Dec 1998) |
| antigen-antibody reaction | The phenomenon, occurring in vitro or in vivo, of antibody combining with antigen of the type that stimulated the formation of the antibody, thereby resulting in agglutination, precipitation, complement fixation, greater susceptibility to ingestion and destruction by phagocytes, or neutralization of exotoxin. See: skin test. (05 Mar 2000) |
| antigen-binding site | <immunology> In immune network theory, an idiotope, an antigenic site of an antibody that is responsible for that antibody binding to an antigenic determinant (epitope). Also used of the site on a ligand molecule to which a cell surface receptor binds. (18 Nov 1997) |
| antigen-combining site | See: paratope. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|